Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition

Pharmacology and Therapeutics

Volumn 138, Issue 1, 2013, Pages 1-17

  Shankar, Sharmila ^a   Kumar, Dhruv ^b   Srivastava, Rakesh K ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

Carcinogenesis; DNA methylation; Epigenetics; Histone modification; Keywords; miRNA; Phytochemicals

Indexed keywords

ANTINEOPLASTIC AGENT; BMI1 PROTEIN; CURCUMIN; DIINDOLYLMETHANE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; E1A ASSOCIATED P300 PROTEIN; ELLAGITANNIN; GARLIC EXTRACT; GENISTEIN; HERBACEOUS AGENT; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; LYCOPENE; PHENETHYL ISOTHIOCYNATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLYCOMB GROUP PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; QUERCETIN; RESVERATROL; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; SIRTUIN 1; SULFORAPHANE; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; BREAST CANCER; BROCCOLI; CANCER CELL; CARCINOGENESIS; CELL CYCLE ARREST; CELL DEATH; CELL DIVISION; CELL GROWTH; CELL SURVIVAL; COLON CANCER; COLORECTAL CANCER; DNA DAMAGE; DNA METHYLATION; DNA PACKAGING; DNA REPAIR; DNA REPLICATION; EPIGENETICS; GARLIC; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; KALE; KIDNEY CANCER; LUNG CANCER; MANTLE CELL LYMPHOMA; MERKEL CELL TUMOR; MYELODYSPLASTIC SYNDROME; NEOPLASM; NONHODGKIN LYMPHOMA; NUTRITION; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SKIN CANCER; STOMACH CANCER; TEA; X CHROMOSOME INACTIVATION;

ANIMALS; DIET; DNA METHYLATION; EPIGENOMICS; HISTONES; HUMANS; NEOPLASMS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PLANTS; RNA, UNTRANSLATED;

EID: 84875217123     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.11.002     Document Type: Review

References (184)

1. S. Ali Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF Cancer Res 70 9 2010 3606 3617
2. T. Ariga, and T. Seki Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review Biofactors 26 2 2006 93 103
3. L. Attig Symposium 2: Modern approaches to nutritional research challenges nutritional developmental epigenomics: immediate and long-lasting effects in the Conference on 'Over- and undernutrition: challenges and approaches Proc Nutr Soc 69 2010 221 231
4. A. Bagchi, and C. Papazoglu CHD5 is a tumor suppressor at human 1p36 Cell 128 3 2007 459 475
5. A. Balakrishnan, and F.E. Bleeker Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma Cancer Res 67 8 2007 3545 3550
6. S. Balasubramanian The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival Carcinogenesis 31 3 2010 496 503
7. S. Balasubramanian, and Y.C. Chew Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells Mol Pharmacol 80 5 2011 870 878
8. K. Balasubramanyam Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription J Biol Chem 279 49 2004 51163 51171
9. S. Banerjee Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic Mutat Res 728 1-2 2011 47 66
10. S. Banerjee, Y. Li, Z. Wang, and F.H. Sarkar Multi-targeted therapy of cancer by genistein Cancer Lett 269 2 2008 226 242
11. S. Barnes Effect of genistein on in vitro and in vivo models of cancer J Nutr 125 Suppl. 3 1995 777S 783S
12. S. Basak, D. Pookot, E.J. Noonan, and R. Dahiya Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function Mol Cancer Ther 7 10 2008 3195 3202
13. J.B. Berletch, C. Liu, W.K. Love, and L.G. Andrews Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG J Cell Biochem 103 2 2008 509 519
14. G. Bora-Tatar, D. Dayangaç-Erden, A.S. Demir, and S. Dalkara Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies Bioorg Med Chem Lett 17 14 2009 5219 5228
15. A. Chase, and N.C. Cross Aberrations of EZH2 in cancer Clin Cancer Res 17 9 2011 2613 2618
16. P.N. Chen, S.C. Chu, W.H. Kuo, M.Y. Chou, J.K. Lin, and Y.S. Hsieh Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells J Agric Food Chem 59 8 2011 3836 3844
17. Y. Chen, W. Shu, W. Chen, and Q. Wu Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells Basic Clin Pharmacol Toxicol 101 6 2007 427 433
18. Q. Chen, S. Ganapathy, K.P. Singh, S. Shankar, and R.K. Srivastava Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells PLoS One 5 12 2010 e15288
19. K.L. Cheung, and A.N. Kong Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention AAPS J 12 1 2010 87 97
20. H.S. Cho, J.H. Park, and Y.J. Kim Epigenomics: novel aspect of genomic regulation Biochem Mol Biol 40 2 2007 151 155
21. S.R. Choudhury, and S. Balasubramanian (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells Carcinogenesis 32 10 2011 1525 1532
22. J.C. Chuang, C.B. Yoo, and J.M. Kwan Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine Mol Cancer Ther 4 10 2005 1515 1520
23. J.D. Clarke, R.H. Dashwood, and E. Ho Multi-targeted prevention of cancer by sulforaphane Cancer Lett 269 2 2008 291 304
24. J.A. Colacino, A.E. Arthur, D.C. Dolinoy, M.A. Sartor, S.A. Duffy, and D.B. Chepeha Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas Epigenetics 7 8 2012 1 9
25. G.F. Combs Jr., L.C. Clark, and B.W. Turnbull An analysis of cancer prevention by selenium Biofactors 14 1-4 2001 153 159
26. D.D. De Carvalho, and J.S. You DNA methylation and cellular reprogramming Trends Cell Biol 20 10 2010 609 617
27. S.E. de Zwaan, and N.K. Haass Genetics of basal cell carcinoma Australas J Dermatol 51 2010 81 92
28. P. Dehan, G. Kustermans, S. Guenin, and J. Horion DNA methylation and cancer diagnosis: new methods and applications Expert Rev Mol Diagn 9 7 2009 651 657
29. H. Denis, M.N. Ndlovu, and F. Fuks Regulation of mammalian DNA methyltransferases: a route to new mechanisms EMBO Rep 12 7 2011 647 656
30. S.E. Dickinson, and T.F. Melton Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: Implications for chemoprevention of UVB-induced skin cancer Cancer Res 69 17 2009 7103 7110
31. J. Drost, and F. Mantovani BRD7 is a candidate tumour suppressor gene required for p53 function Nat Cell Biol 12 4 2010 380 389
32. N. Druesne, A. Pagniez, C. Mayeur, and M. Thomas Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines Carcinogenesis 25 7 2004 1227 1236
33. S.J. Duthie Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis J Inherit Metab Dis 34 1 2011 101 109
34. S.J. Duthie Epigenetic modifications and human pathologies: cancer and CVD Proc Nutr Soc 70 1 2011 47 56
35. M.Z. Fang, Y. Wang, N. Ai, and Z. Hou Tea polyphenol (-)- epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Res 63 22 2003 7563 7570
36. M.Z. Fang, D. Chen, Y. Sun, and Z. Jin Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy Clin Cancer Res 11 19 Pt 1 2005 7033 7041
37. Z. Fazekas, and D. Gao Protective effects of lycopene against ultraviolet B-induced photodamage Nutr Cancer 47 2 2003 181 187
38. M.E. Figueroa, and O. Abdel-Wahab Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 6 2010 553 567
39. P. Filippakopoulos, and J. Qi Selective inhibition of BET bromodomains Nature 468 7327 2010 1067 1073
40. J.L. Fischer, J.K. Lancia, A. Mathur, and M.L. Smith Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex Anticancer Res 26 2A 2006 899 904
41. L.N. Fix, M. Shah, T. Efferth, and M.A. Farwell MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60 Cancer Genomics Proteomics 7 5 2010 261 277
42. S. Ganapathy, Q. Chen, K.P. Singh, S. Shankar, and R.K. Srivastava Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor PLoS One 5 12 2010 e15627
43. Z. Gao, Z. Xu, M.S. Hung, and Y.C. Lin Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells Anticancer Res 29 6 2009 2025 2030
44. R. Garzon, G.A. Calin, and C.M. Croce MicroRNAs in Cancer Annu Rev Med 60 2009 167 179
45. V. Gelsi-Boyer, and M. Brecqueville Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases J Hematol Oncol 5 2012 12
46. J. George, and M. Singh Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53 PLoS One 6 8 2011 e23395
47. L. Gibellini, M. Pinti, M. Nasi, and J.P. Montagna Quercetin and cancer chemoprevention Evid Based Complement Alternat Med 2011 591356 2011 1 15
48. E. Giovannucci Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature J Natl Cancer Inst 91 4 1999 317 331
49. A.D. Goldberg, C.D. Allis, and E. Bernstein Epigenetics: a landscape takes shape Cell 128 4 2007 635 638
50. B. Gu, Q. Ding, G. Xia, and Z. Fang EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression Oncol Rep 21 3 2009 635 640
51. B. Guan, and T.L. Mao Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma Am J Surg Pathol 35 5 2011 625 632
52. T.M. Hardy, and T.O. Tollefsbol Epigenetic diet: impact on the epigenome and cancer Epigenomics 3 4 2011 503 518
53. R.D. Hawkins, G.C. Hon, C. Yang, J.E. Antosiewicz-Bourget, L.K. Lee, and Q.M. Ngo Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency Cell Res 21 10 2011 1393 1409
54. D. Heber Multi-targeted therapy of cancer by ellagitannins Cancer Lett 269 2 2008 262 268
55. E. Ho, L.M. Beaver, D.E. Williams, and R.H. Dashwood Dietary factors and epigenetic regulation for prostate cancer prevention Adv Nutr 2 6 2011 497 510
56. A. Hoischen, and B.W. van Bon De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome Nat Genet 43 8 2011 729 731
57. G.C. Hon, R.D. Hawkins, and B. Ren Predictive chromatin signatures in the mammalian genome Hum Mol Genet 18 R2 2009 R195 R201
58. T. Hong, T. Nakagawa, W. Pan, and M.Y. Kim Isoflavones stimulate estrogen receptor-mediated core histone acetylation Biochem Biophys Res Commun 317 1 2004 259 264
59. S. Hsu, and D. Dickinson Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model Exp Dermatol 16 8 2007 678 684
60. J.P. Issa, and H.M. Kantarjian Targeting DNA methylation Clin Cancer Res 15 12 2009 3938 3946
61. A. Izzotti, G.A. Calin, V.E. Steele, and C. Cartiglia Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs Cancer Prev Res (Phila) 3 1 2010 62 72
62. A. Izzotti, P. Larghero, C. Cartiglia, and M. Longobardi Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung Carcinogenesis 31 5 2010 894 901
63. P. Jelinic, and P. Shaw Loss of imprinting and cancer J Pathol 211 3 2007 261 268
64. L. Jiang, and J. Li Bmi-1, stem cells and cancer Acta Biochim Biophys Sin (Shanghai) 41 7 2009 527 534
65. Y. Jin, X. Zou, and X. Feng 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells Anticancer Drugs 21 9 2010 814 822
66. P.A. Jones DNA methylation and cancer Oncogene 21 35 2002 5358 5360
67. S. Jones, and T.L. Wang Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma Science 330 2010 228 231
68. Y. Kanai, and S. Ushijima Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers Cancer Lett 192 1 2003 75 82
69. J. Kang, and J. Chen Curcumin-induced histone hypoacetylation: The role of reactive oxygen species Biochem Pharmacol 69 8 2005 1205 1213
70. S. Katiyar, and C.A. Elmets Green tea and skin cancer: Photoimmunology, angiogenesis and DNA repair J Nutr Biochem 18 5 2007 287 296
71. K. Kato, N.K. Long, H. Makita, and M. Toida Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells Br J Cancer 99 4 2008 647 654
72. N. Kikuno, H. Shiina, S. Urakami, and K. Kawamoto Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells Int J Cancer 123 3 2008 552 560
73. Y.I. Kim Folate and colorectal cancer: an evidence-based critical review Mol Nutr Food Res 51 3 2007 267 292
74. J.W. Kim, A.R. Amin, and D.M. Shin Chemoprevention of head and neck cancer with green tea polyphenols Cancer Prev Res 3 8 2010 900 909
75. M.S. Kim, and N.G. Chung Genetic and expressional alterations of CHD genes in gastric and colorectal cancers Histopathology 58 5 2011 660 668
76. A. King-Batoon, J.M. Leszczynska, and C.B. Klein Modulation of gene methylation by genistein or lycopene in breast cancer cells Environ Mol Mutagen 49 1 2008 36 45
77. T.M. Kok, S.G. Breda, and B.JJ Genomics-based identification of molecular mechanisms behind the cancer preventive action of phytochemicals: potential and challenges Curr Pharm Biotechnol 13 1 2012 255 264
78. C.E. Kupchella Environmental factors in cancer etiology Semin Oncol Nurs 2 3 1986 161 169
79. C. Kürbitz, D. Heise, and T. Redmer Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells Cancer Sci 102 4 2011 728 734
80. J. Lan, S. Hua, X. He, and Y. Zhang DNA methyltransferases and methyl-binding proteins of mammals Acta Biochim Biophys Sin 42 4 2010 243 252
81. M.A. Lea, V.M. Randolph, and M. Patel Increased acetylation of histones induced by diallyl disulfide and structurally related molecules Int J Oncol 15 2 1999 347 352
82. M.A. Lea, V.M. Randolph, J.E. Lee, and C. desBordes Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate Int J Cancer 92 6 2001 784 789
83. M.A. Lea, M. Rasheed, V.M. Randolph, and F. Khan Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine Nutr Cancer 43 1 2002 90 102
84. W.J. Lee, J.Y. Shim, and B.T. Zhu Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids Mol Pharmacol 68 4 2005 1018 1030
85. W.J. Lee, Y.R. Chen, and T.H. Tseng Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells Oncol Rep 25 2 2011 583 591
86. T.J. Ley, and L. Ding DNMT3A mutations in acute myeloid leukemia N Engl J Med 363 25 2010 2424 2433
87. M. Lemire, M. Fillion, F. Barbosa Jr., J.R. Guimaraes, and D. Mergler Elevated levels of selenium in the typical diet of Amazonian riverside populations Sci Total Environ 408 19 2010 4076 4084
88. Q. Li, and H. Chen Silencing of Wnt5a during colon cancer metastasis involves histone modifications Epigenetics 7 6 2012 551 558
89. Y. Li, T.G. VandenBoom II, D. Kong, and Z. Wang Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells Cancer Res 69 16 2009 6704 6712
90. Y. Li, X. Li, and B. Guo Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases Cancer Res 70 2 2010 646 654
91. Y. Li, T.G. VandenBoom II, Z. Wang, and D. Kong miR-146a suppresses invasion of pancreatic cancer cells Cancer Res 70 4 2010 1486 1495
92. M. Li, and H. Zhao Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma Nat Genet 43 9 2011 828 829
93. U. Lim, and M.A. Song Dietary and lifestyle factors of DNA methylation Methods Mol Biol 863 2012 359 376
94. H.L. Liu, Y. Chen, G.H. Cui, and J.F. Zhou Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation Acta Pharmacol Sin 26 5 2005 603 609
95. H.L. Liu, Y. Chen, G.H. Cui, and J.F. Zhou Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation Acta Pharmacol Sin 26 5 2005 603 609
96. Z. Liu, Z. Xie, W. Jones, and R.E. Pavlovicz Curcumin is a potent DNA hypomethylation agent Bioorg Med Chem Lett 19 3 2009 706 709
97. C. Lu, and P.S. Ward IDH mutation impairs histone demethylation and results in a block to cell differentiation Nature 483 2012 474 478
98. R.U. Lukacs, and S. Memarzadeh Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation Cell Stem Cell 7 6 2010 682 693
99. M. Macaluso, M.G. Paggi, and A. Giordano Genetic and epigenetic alterations as hallmarks of the intricate road to cancer Oncogene 22 42 2003 6472 6478
100. S. Majid, A.A. Dar, A.E. Ahmad, and H. Hirata BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer Carcinogenesis 30 4 2009 662 670
101. S. Majid, A.A. Dar, S. Saini, and Y. Chen Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer Cancer Res 70 7 2010 2809 2818
102. S. Majid, A.A. Dar, V. Shahryari, and H. Hirata Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer Cancer 116 1 2010 66 76
103. S. Majid, N. Kikuno, J. Nelles, and E. Noonan Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification Cancer Res 68 8 2008 2736 2744
104. M.G. Marcu, Y.J. Jung, S. Lee, and E.J. Chung Curcumin is an inhibitor of p300 histone acetylatransferase Med Chem 2 2 2006 169 174
105. L. Mattera, and F. Escaffit The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways Oncogene 28 12 2009 1506 1517
106. J.L. Medina-Franco, F. López-Vallejo, D. Kuck, and F. Lyko Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach Mol Divers 15 2 2011 293 304
107. S.M. Meeran, S.N. Patel, and T.O. Tollefsbol Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines PLoS One 5 7 2010 e11457
108. A.A. Mills Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins Nat Rev Cancer 10 10 2010 669 682
109. A. Miremadi, and M.Z. Oestergaard Cancer genetics of epigenetic genes Hum Mol Genet 16 2007 28 49
110. R.D. Morin, and M. Mendez-Lago Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma Nature 476 7360 2011 298 303
111. G. Mudduluru, J.N. George-William, S. Muppala, and I.A. Asangani Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer Biosci Rep 31 3 2011 185 197
112. R.S. Murugan, G. Vinothini, Y. Hara, and S. Nagini Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model Anticancer Res 29 6 2009 2301 2305
113. M.C. Myzak, P.A. Karplus, F.L. Chung, and R.H. Dashwood A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase Cancer Res 64 16 2004 5767 5774
114. M.C. Myzak, W.M. Dashwood, G.A. Orner, and E. Ho Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice FASEB J 20 3 2006 506 508
115. M.C. Myzak, K. Hardin, R. Wang, and R.H. Dashwood Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells Carcinogenesis 27 4 2006 811 819
116. M.C. Myzak, P. Tong, W.M. Dashwood, and R.H. Dashwood Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects Exp Biol Med (Maywood) 232 2 2007 227 234
117. V. Nandakumar, and M. Vaid (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells Carcinogenesis 32 4 2011 537 544
118. E. Navarro-Perán, J. Cabezas-Herrera, L.S. del Campo, and J.N. Rodríguez-López Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate Int J Biochem Cell Bio 39 12 2007 2215 2225
119. M. Pandey, S. Shukla, and S. Gupta Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells Int J Cancer 126 11 2010 2520 2533
120. M.A. Parasramka, E. Ho, D.E. Williams, and D. RH MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals Mol Carcinog 51 3 2012 213 230
121. L.P. Parker, D.D. Taylor, J. Kesterson, and D.S. Metzinger Modulation of microRNA associated with ovarian cancer cells by genistein Eur J Gynaecol Oncol 30 6 2009 616 621
122. A. Pledgie-Tracy, M.D. Sobolewski, and N.E. Davidson Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines Mol Cancer Ther 6 3 2007 1013 1021
123. I.P. Pogribny, S.A. Ross, C. Wise, M. Pogribna, E.A. Jones, and V.P. Tryndyak Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency Mutat Res 593 1-2 2006 80 87
124. L.A. Poirier Methyl group deficiency in hepatocarcinogenesis Drug Metab Rev 26 1-2 1994 185 199
125. R.V. Priyadarsini, G. Vinothini, R.S. Murugan, and P. Manikandan The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors Nutr Cancer 63 2 2011 218 226
126. W. Qin, W. Zhu, H. Shi, and J.E. Hewett Soy isoflavones have an anti-estrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women Nutr Cancer 61 2 2009 238 244
127. P. Rajendran, E. Ho, D.E. Williams, and R.H. Dashwood Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells Clin Epigenetics 3 1 2011 4
128. Z.H. Ran, J. Zou, and S.D. Xiao Experimental study on anti-neoplastic activity of epigallocatechin-3-gallate to digestive tract carcinomas Chin Med J (Engl) 118 16 2005 1330 1337
129. C. Redman, J.A. Scott, A.T. Baines, J.L. Basye, L.C. Clark, and C. Calley Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines Cancer Lett 125 1-2 1998 103 110
130. S. Ropero, and M.F. Fraga A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition Nat Genet 38 5 2006 566 569
131. D. Rotili Targeting histone demethylases: A new avenue for the fight against cancer Genes Cancer 2 2011 663 679
132. S.K. Roy, R.K. Srivastava, and S. Shankar Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer J Mol Signal 5 2010 10
133. S.K. Roy, Q. Chen, J. Fu, S. Shankar, and R.K. Srivastava Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors PLoS One 6 9 2011 e25166
134. P.A. Ruiz, A. Braune, G. Hölzlwimmer, and L. Quintanilla-Fend Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells J Nutr 137 5 2007 1208 1215
135. O.J. Sansom, and K. Maddison Mechanisms of disease: Methyl-binding domain proteins as potential therapeutic targets in cancer Nat Clin Pract Oncol 4 5 2007 305 315
136. J.F. Savouret, and M. Quesne Resveratrol and cancer: a review Biomed Pharmacother 56 2 2002 84 87
137. C.L. Saw, and M.T. Huang Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane Mol Carcinog 50 6 2011 479 486
138. C. Sawan, and Z. Herceg Histone modifications and cancer Adv Genet 70 2010 57 85
139. S. Shankar, and S. Ganapathy Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis Clin Cancer Res 14 21 2008 6855 6866
140. S. Shankar, D. Nall, S.N. Tang, D. Meeker, J. Passarini, and J. Sharma Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition PLoS One 6 1 2011 e16530
141. M.K. Shanmugam, R. Kannaiyan, and G. Sethi Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer Nutr Cancer 63 2 2011 161 173
142. H. Shen, and L. Wang A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer Cancer Res 62 17 2002 4992 4995
143. I.A. Siddiqui, V.M. Adhami, M. Saleem, and H. Mukhtar Beneficial effects of tea and its polyphenols against prostate cancer Mol Nutr Food Res 50 2 2006 130 143
144. B.N. Singh, S. Shankar, and R.K. Srivastava Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications Biochem Pharmacol 82 12 2011 1807 1821
145. R.K. Srivastava, T.G. Unterman, and S. Shankar FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol Mol Cell Biochem 337 1-2 2010 201 212
146. B. Stefanska, K. Rudnicka, A. Bednarek, and K. Fabianowska-Majewska Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells Eur J Pharmacol 638 1-3 2010 47 53
147. B. Stefanska, H. Karlic, F. Varga, K. Fabianowska-Majewska, and A.G Haslberger Epigenetic mechanisms in anti-cancer actions of bioactive food components-the implications in cancer prevention Br J Pharmacol 167 2 2012 279 297
148. C.J. Stein, and G.A. Colditz Modifiable risk factors for cancer Br J Cancer 90 2 2004 299 303
149. T. Suganuma, and J.L. Workman Signals and combinatorial functions of histone modifications Annu Rev Biochem 80 2011 473 499
150. A. Sun, and O. Tawfik Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers Prostate 67 2 2007 203 213
151. M. Sun, Z. Estrov, Y. Ji, and K.R. Coombes Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells Mol Cancer Ther 7 3 2008 464 473
152. Q. Sun, R. Cong, H. Yan, and H. Gu Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression Oncol Rep 22 3 2009 563 567
153. S. Tan, and C. Wang Quercetin is able to demethylate the p16INK4a gene promoter Chemotherapy 55 1 2008 6 10
154. A.Y. Tan, and J.L. Manley The TET family of proteins: Functions and roles in disease J Mol Cell Biol 1 2 2009 82 92
155. S.N. Tang, C. Singh, D. Nall, D. Meeker, S. Shankar, and R.K. Srivastava The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition J Mol Signal 5 2010 14
156. S.N. Tang, J. Fu, S. Shankar, and R.K. Srivastava EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer PLoS One 7 2 2012 e31067
157. M.H. Teiten, S. Eifes, M. Dicato, and Marc Diederich Curcumin-The paradigm of a multi-target natural compound with applications in cancer prevention and treatment Toxins 2 1 2010 128 162
158. E. Tili, J.J. Michaille, H. Alder, and S. Volinia Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells Biochem Pharmacol 80 12 2010 2057 2065
159. M. Traka, A.V. Gasper, J.A. Smith, and C.J. Hawkey Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane J Nutr Biochem 135 8 2005 1865 1872
160. W.P. Tsang, and T.T. Kwok Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells J Nutr Biochem 21 2 2010 140 146
161. D.P. Tsang, and A.S. Cheng Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2 J Gastroenterol Hepatol 26 1 2011 19 27
162. S.H. Tu, C.Y. Ku, and C.T. Ho Tea polyphenol (-)-epigallocatechin-3- gallate inhibits nicotineand estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells Mol Nutr Food Res 55 3 2011 455 466
163. I. Varela, and P. Tarpey Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 7331 2011 539 542
164. R.A. Varier, and H.T. Timmers Histone lysine methylation and demethylation pathways in cancer Biochim Biophys Acta 1815 1 2011 75 89
165. S.R. Volate, S.J. Muga, A.Y. Issa, and D. Nitcheva Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer Mol Carcinog 48 10 2009 920 933
166. L.G. Wang, A. Beklemisheva, X.M. Liu, and A.C. Ferrari Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer Mol Carcinog 46 1 2007 24 31
167. R.H. Wang, Y. Zheng, H.S. Kim, and X. Xu Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis Mol Cell 32 1 2008 11 20
168. J. Wang, Z. Wu, D. Li, N. Li, S.V. Dindot, and M.C. Satterfield Nutrition, epigenetics, and metabolic syndrome Antioxid Redox Signal 17 2 2012 282 301
169. X.Y. Wen, S.Y. Wu, Z.Q. Li, and Z.Q. Liu Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of miRNAs in HepG2 cancer cells Phytother Res 23 6 2009 778 784
170. K. Wessels, and B. Bohnhorst Novel CHD7 mutations contributing to the mutation spectrum in patients with CHARGE syndrome Eur J Med Genet 53 5 2010 280 285
171. C. Wijmenga, and R.S. Hansen Genetic variation in ICF syndrome: evidence for genetic heterogeneity Hum Mutat 16 6 2000 509 517
172. B.G. Wilson, and C.W. Roberts SWI/SNF nucleosome remodellers and cancer Nat Rev Cancer 11 2011 481 492
173. S.C. Wu, and Y. Zhang Active DNA demethylation: Many roads lead to Rome Nat Rev Mol Cell Biol 11 9 2010 607 620
174. N. Xiang, R. Zhao, G. Song, and W. Zhong Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells Carcinogenesis 29 11 2008 2175 2181
175. G.S. Xiao, Y.S. Jin, Q.Y. Lu, and Z.F. Zhang Annexin-I as a potential target for green tea extract induced actin remodeling Int J Cancer 120 1 2006 111 120
176. C. Xu, and M.T. Huang Inhibition of 7,12-dimethylbenz(a)anthracene- induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2 Cancer Res 66 16 2006 8293 8296
177. Y. Yamashita, and J. Yuan Array-based genomic resequencing of human leukemia Oncogene 29 25 2010 3723 3731
178. Q. Yang, R.M. Bostick, J.M. Friedman, and W.D. Flanders Serum folate and cancer mortality among U.S. adults: findings from the Third National Health and Nutritional Examination Survey linked mortality file Cancer Epidemiol Biomarkers Prev 18 5 2009 1439 1447
179. J. Yang, Y. Cao, J. Sun, and Y. Zhang Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells Med Oncol 27 4 2010 1114 1118
180. Yaoting Gui, and Guangwu Guo Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder Nat Genet 43 2011 875 878
181. Y. Yuasa, H. Nagasaki, Y. Akiyama, and H. Sakai Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients Carcinogenesis 26 1 2005 193 200
182. J. Zhang, and T. Zhang Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway Biochem Biophys Res Commun 399 1 2010 1 6
183. P. Zhuo, and A.M. Diamond Molecular mechanisms by which selenoproteins affect cancer risk and progression Biochim Biophys Acta 1790 11 2009 1546 1554
184. J. Zuber, and J. Shi RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Nature 478 7370 2011 524 528